¿El Tratamiento de la Fibrilación Auricular Podría Disminuir el Riesgo de Deterioro Cognitivo y Demencia?

¿El Tratamiento de la Fibrilación Auricular Podría Disminuir el Riesgo de Deterioro Cognitivo y Demencia?. (2023). Ictus, 4(1), e23022304003. https://doi.org/10.5281/zenodo.7671008

Resumen

Carta al editor sobre "¿El Tratamiento de la Fibrilación Auricular Podría Disminuir el Riesgo de Deterioro Cognitivo y Demencia?" presentada en el volumen 4 número 1 de 2023 de ICTUS.

PDF Carta al Editor

Referencias

Santiago J, Potashkin J. The Impact of Disease Comorbidities in Alzheimer's Disease. Front. Aging Neurosci. 2021;13(631770):1-13. https://doi.org/10.3389/fnagi.2021.631770

Gallinoro E, D'Elia S, Prozzo D, Lioncino M, Natale F, Golino P, et al. Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance?. Medicina. 2019;55(9):587. https://doi.org/10.3390/medicina55090587

Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76(10):914-22. https://doi.org/10.1212/WNL.0b013e31820f2e38

Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, et al. Atrial fibrillation patients treated with long-term warfarin anticoagulation have higher rates of all dementia types compared with patients receiving long-term warfarin for other indications. J Am Heart Assoc. 2016;5:e003932. https://doi.org/10.1161/JAHA.116.003932

Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012;184(6):E329-36. https://doi.org/10.1503/cmaj.111173

Dietzel J, Haeusler K, Endres M. Does atrial fibrillation cause cognitive decline and dementia? EP Europace. 2018;20(3):408-19. https://doi.org/10.1093/europace/eux031

Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, et al. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm. 2014;11:2206-13. https://doi.org/10.1016/j.hrthm.2014.08.013

Lin T, Wissner E, Tilz R, Rillig A, Mathew S, Rausch P, et al. Preserving Cognitive Function in Patients with Atrial Fibrillation. J atrial fibrillation. 2014;7(1):980. https://doi.org/10.4022/jafib.980

Ihara M, Washida K. Linking Atrial Fibrillation with Alzheimer’s Disease: Epidemiological, Pathological, and Mechanistic Evidence. IOS Press. 2018;62(1):61-72. https://doi.org/10.3233/JAD-170970

Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, et al. Long-term population-based cerebral ischemic event and cognitive outcomes of direct oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation. Am J Cardiol. 2016;118:210-4. https://doi.org/10.1016/j.amjcard.2016.04.039

Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. 2018;39(6):453-460. https://doi.org/10.1093/eurheartj/ehx579

Bunch T. Atrial Fibrillation and Dementia. Circulation. 2020;142(7):618-620. https://doi.org/10.1161/CIRCULATIONAHA.120.045866

Ferreira R, Madeira C, Tse G, Roever L. Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation. Front. Neurosci. 2019;13(18):1-7. https://doi.org/10.3389/fnins.2019.00018

Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J. Am. Coll. Cardiol. 2013;62:531-9. https://doi.org/10.1016/j.jacc.2013.03.073